(Q86012349)
Statements
First-in-man phase I study of GC33, a novel recombinant humanized antibody against glypican-3, in patients with advanced hepatocellular carcinoma (English)
Andrew X Zhu
Philip J Gold
Anthony B El-Khoueiry
Thomas A Abrams
Hideo Morikawa
Norihisa Ohishi
Toshihiko Ohtomo
Philip A Philip
29 January 2013